News of the expanded cost-reduction drive came as Pfizer recorded 1% sales growth to $15 billion, driven by continued strong ...

A one-time $5.7 billion charge related to the just-completed $6.7 billion takeover of Terns Pharma and its oral BCR-ABL ...

The criteria developed by UK health technology assessment (HTA) agency NICE to decide who should be referred by GPs for ...

Pathos AI has added to its pipeline of cancer drugs by licensing a bispecific antibody-drug conjugate (ADC) for solid tumours ...

Expanded APAC expertise, enhanced global infrastructure, and AI-enabled innovation help life sciences organizations generate actionable insights from every scientific interaction. PHILADELPHIA, PA – ...

Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry. A Harvard ...

Henry Gosebruch, pictured here during his time at Neumora, is replacing Paul Stoffels as CEO of Galapagos. Just a few months after announcing a plan to separate its drug and cell therapy businesses ...

Four Democratic senators are investigating whether the family of HHS Secretary Robert F Kennedy Jr is profiting from what they assert are "bogus" vaccine lawsuits. In particular, they want to know if ...

Hydroxychloroquine, the anti-malaria drug controversially used to fight COVID-19, was trending again after a string of retweets from president Donald Trump in favour of the medicine. Trump has ...

GSK just hit one of its main objectives for 2025 after getting FDA approval of anti-IL-5 antibody Nucala as a treatment for chronic obstructive pulmonary disease (COPD). Nucala (mepolizumab) has been ...

Health tech firm Datavant has reached an agreement to acquire Aetion, a specialist in real-world evidence (RWE), pooling their resources in the category as RWE moves into mainstream use in healthcare ...

Two top healthcare investors – UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category with $21 billion in assets under management. The combined ...